Bio-Techne fiscal Q3 sales rise 1% on strength in cell therapy, prostate test products
Bio-Techne on Wednesday reported fiscal third-quarter sales of $294.1 million, up 1% compared to $290.4 million in the prior-year quarter and short of analysts’ average estimate of $296.7 million. Read More
Viral peptides improve CRISPR-Cas gene editing to expand cell therapy applications
Scientists have used viral peptides to get CRISPR-Cas gene editing molecules into cells more efficiently and with minimal toxicity, suggesting the method can improve the production of cell and gene therapies. Read More
Researchers modify lentivirus to enable targeted delivery of muscle disease gene therapy
Researchers have created a lentiviral gene therapy vector capable of targeting muscle cells to treat the rare disease Duchenne muscular dystrophy (DMD) in mice. Read More
Unique membrane protein stops viral infection in bacteria
University of Rochester Medical Center (URMC) researchers revealed a previously unrecognized player in the CRISPR system: a membrane protein that enhances antiviral defense. The study, published Thursday in Science, broadens the current understanding of CRISPR’s complexities. Read More
Benchtop DNA printing on DNA Day
Geared up for DNA Day on April 25, Sylvain Gariel, co-founder and chief operating officer of DNA Script, spoke to Stephen Wellman, director of content and strategy of LabPulse and The Science Advisory Board, about DNA’s impact on diagnostics, genomics, and molecular biology research. Read More
Reanalysis of old data reveals overlooked liver gene therapy vector with better properties
Rational design and directed evolution have created an adeno-associated virus (AAV) capsid that is better at targeting the liver, setting the stage for its use as a gene therapy vector. Read More
Bio-Techne, Lunaphore partner to develop a fully automated spatial multiomics workflow
Bio-Techne and Lunaphore on Monday announced a strategic partnership to develop a fully automated spatial multiomics workflow with same-slide hyperplex detection of protein and RNA biomarkers. Read More
Report identifies bias factors in clinical genetic testing
The American College of Medical Genetics and Genomics (ACMG) on Friday published a statement on reducing bias in clinical genetic testing. Read More
RNA sequencing database reveals how mutations accrue in different tissues as humans age
The application of bulk RNA sequencing to samples from almost 1,000 donors has created an atlas of the mutations that accrue in different tissues as people age. Read More
Agilent Technologies launches pan-cancer NGS assay for solid tumors
Agilent Technologies on Thursday announced the launch of the Agilent SureSelect Cancer CGP Assay, a pan-cancer assay for comprehensive molecular profiling of a broad range of solid tumors. Read More
Science Briefs
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter